August 31, 2023: On Wednesday, HP Inc. stock decreases after earnings disappoint. HP reported $13.2 billion in earnings, below the $13.37 billion anticipated by …
August 30, 2023: On Tuesday, Toyota stopped 12 plants in its home market and added the previous two in the afternoon. The glitch prevents Toyota from including members, and its …
August 30, 2023: The iPhone 15 series launch event date officially revealed in its headquarters in Cupertino, California. The new iPhone models, probably branded as …
August 29, 2023: On Monday, Foxconn Founder Upends Taiwan Vote by Launching Presidential Bid but dropped out after failing to win the nomination for Taiwan’s main rival …
August 28, 2023: Officials in Hawaii are urging tourists to come to Maui to help keep the economy as unemployment claims surge on the island …
August 28, 2023: India’s historic Moon landing took lesser amount than to make Interstellar. Even in the modern era, the track record still needs to …
August 28, 2023: On Friday, Instacart, the grocery delivery firm, slashed its valuation during the previous year’s market …
Suyi Erhabor, CEO, Curaga, has been crucial to the creation and transformation of Curaga from a small business to a multimillion-dollar corporation in Ontario. Suyi treats each employee as a valued individual and takes the time to understand what motivates them. Being a steadfast leader, he remains accessible to all his staff, and they ensure to reach him directly when there is a problem and to share stories of success.
Sasha Jensen is the founder and CEO of Jensen Partners, a leading global executive search firm, and Jensen DiversityMetrics™, the enterprise software solution for workforce diversity, equity, and inclusion. As the woman at the helm of both organizations, Sasha is a leading expert on talent markets for capital raising and investment professionals across the alternative investment industry.
Patrick Lu, Founder, President, and CEO of Sirnaomics, is discovering and developing innovative RNA therapeutics with small interfering RNA (siRNA) and message RNA (mRNA) as novel modalities. Armed with more than 25 years of biopharmaceutical industry experience with big pharma and start-up environments for nucleic acid therapeutics, Patrick has been able to mitigate challenges and difficulties throughout Sirnaomics’ growth and development, and transform the company from a humble start-up to an internationally recognized public entity.